Skip to main content
. Author manuscript; available in PMC: 2015 Feb 11.
Published in final edited form as: J Neurooncol. 2014 Nov 28;121(3):573–581. doi: 10.1007/s11060-014-1669-x

Fig. 1.

Fig. 1

Progression free survival (PFS) and overall survival (OS) for the midline HGG cohort. The x-axis is time (months) and the y-axis represents the proportion of surviving patients